top of page

Bridging Science and Society: Insights from Dr. Bandar Aloisimi on High Impact Translational Research

  • Writer: Lal Kabalak
    Lal Kabalak
  • Jun 17
  • 2 min read

2 min read 407 words


On April 30th, we were privileged to attend an illuminating webinar titled “Towards High Impact Translational Research”, featuring Dr. Bandar Aloisimi — a distinguished figure known for his dedication to transforming research into tangible societal benefits. His talk addressed a question central to modern science: How do we ensure that cutting-edge research doesn’t just end in journals, but reaches the people and systems that need it most?


Dr. Aloisimi began by defining translational research not simply as the act of moving lab findings into clinics or products, but as a strategic process rooted in purpose, collaboration, and adaptability. “We must think beyond publication,” he urged, “and toward implementation — toward impact.”


He shared key pillars for achieving high-impact outcomes:


Problem-Centered Research

Dr. Aloisimi emphasized the importance of beginning with real-world problems, not just academic curiosity. “Too often, research is driven by what is publishable, not what is actionable,” he said. He encouraged institutions to recalibrate incentives and measure success not just by citations, but by solutions delivered.

 

Interdisciplinary Collaboration

He advocated for cross-sector collaboration — between clinicians, social scientists, engineers, policymakers, and communities. Translational research, he noted, thrives when multiple perspectives are brought together early in the process. “It’s not enough to invite collaborators after the project is designed,” he warned. “They must be co-creators.”

 

Systemic Thinking and Policy Integration

Dr. Aloisimi stressed that high-impact translational work must account for systems, not just symptoms. Effective interventions often require engaging with healthcare infrastructure, education systems, and government policies. Research must be designed with these implementation pathways in mind.


From Pilots to Scale

Citing examples from health tech innovations and public health campaigns, he spoke about the 'pilot trap' — where promising initiatives never reach broader populations. Scaling requires early planning, stakeholder engagement, and robust impact measurement tools.


Capacity Building and Leadership

Finally, Dr. Aloisimi highlighted the need to train researchers differently — not just as scientists, but as translators, communicators, and leaders. “Leadership is not optional,” he said. “It’s central to making sure ideas live beyond the lab.”


Final Reflections

Dr. Aloisimi’s message was clear: Research excellence must be coupled with societal relevance. The future belongs to those who can cross boundaries — between academia and community, innovation and equity, data and humanity.

At iWisdom, we’re inspired by his vision. As we continue to support interdisciplinary thinking and socially responsive research, we’re reminded that impact is not a buzzword — it’s a responsibility.

 


Comments


iWisdom BUSINESS PARTNERS LTD, registered as a limited company in England and Wales under company number: 04803587. 

Registered Company Address: 85 Great Portland Street, First Floor, London, England, W1W 7LT

Terms of Use | Privacy & Cookie Policy | Trading Terms

© 2024. The content on this website is owned by us and our licensors. Do not copy any content (including images) without our consent.

bottom of page